Neuropathic Back Pain – Epidemiology – Middle East and Africa
Clarivate Epidemiology’s coverage of neuropathic back pain comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of neuropathic back pain for each country, as well as annualized case counts projected to the national population. Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.
Clarivate Epidemiology’s neuropathic back pain forecast will answer the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of neuropathic back pain over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Note: Coverage may vary by country.
Table of contents
- Neuropathic Back Pain - Epidemiology - Middle East and Africa
- Introduction
- Key Findings
- Total Prevalence of Neuropathic Back Pain per 100 People Aged 20+ in 2021
- Total Prevalence of Neuropathic Back Pain per 100 People Aged 20+ in 2021 and 2031
- Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Neuropathic Back Pain Over the Next 10 Years
- Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Neuropathic Back Pain Over the Next 10 Years
- Epidemiology Data
- Methods
- Reference Materials
- Introduction
